Article
Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.
Antimicrobial agents and chemotherapy - 1 May 2012
Martin Rowena E, Butterworth Alice S, Gardiner Donald L, Kirk Kiaran, McCarthy James S, Skinner-Adams Tina S
Abstract excerpt
The antiretroviral protease inhibitors (APIs) ritonavir, saquinavir, and lopinavir, used to treat HIV infection, inhibit the growth of Plasmodium falciparum at clinically relevant concentrations. Moreover, it has been reported that these APIs potentiate the activity of chloroquine (CQ) against this parasite in vitro. The mechanism underlying this effect is not understood, but the degree of chemosensitization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
